nach oben

Journal of Cardiovascular Translational Research

Erschienen in:

02.01.2019 | Original Article

A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience

verfasst von: Leor Perl, Elina Soifer, Jozef Bartunek, Dedi Erdheim, Friedrich Köhler, William T. Abraham, David Meerkin

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

The V-LAP™ measures left atrial pressure (LAP) and enables bi-directional communications with an external unit, designed to monitor heart failure patients. We hereby describe the pre-clinical experience. Following an ex vivo phase, the system was implanted at the interatrial septum of 10 ovine subjects. LAP readouts were compared with pulmonary capillary wedge pressure (PCWP) at index procedure and 1, 2 and 3–6 months after the implantation, at rest and after volume loading. Histopathology assessment (n = 8) was performed up to 50 weeks post procedure. Procedural success was 100%. Measurements showed a mean difference of 0.19 ± 2.51 mmHg. During this period, correlation of V-LAP™ with PCWP was excellent (R² = 0.95, for 119 total measurements). There were no major adverse events related to the V-LAP™ system. In an animal model, the implantation of the novel wireless left atrial pressure sensor V-LAP™ was feasible, safe, and showed good accuracy and precision.

Jencks, S. F., Williams, M. V., & Coleman, E. A. (2009). Rehospitalizations among patients in the Medicare fee-for-service program. New England Journal of Medicine, 360(14), 1418–1428. https://doi.org/10.1056/NEJMsa0803563.CrossRef

Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., …, & American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2014). Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation, 129(3), e28–e292. https://doi.org/10.1161/01.cir.0000441139.02102.80.

Kociol, R. D., Hammill, B. G., Fonarow, G. C., Klaskala, W., Mills, R. M., Hernandez, A. F., & Curtis, L. H. (2010). Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. American Heart Journal, 160(5), 885–892. https://doi.org/10.1016/j.ahj.2010.07.020.CrossRefPubMed

Chun, S., Tu, J. V., Wijeysundera, H. C., Austin, P. C., Wang, X., Levy, D., & Lee, D. S. (2012). Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circulation: Heart Failure, 5(4), 414–421. https://doi.org/10.1161/CIRCHEARTFAILURE.111.964791.CrossRef

Lee, D. S., Austin, P. C., Stukel, T. A., Alter, D. A., Chong, A., Parker, J. D., & Tu, J. V. (2009). “Dose-dependent” impact of recurrent cardiac events on mortality in patients with heart failure. The American Journal of Medicine, 122(2), 162–169.e1. https://doi.org/10.1016/j.amjmed.2008.08.026.CrossRefPubMed

Setoguchi, S., Stevenson, L. W., & Schneeweiss, S. (2007). Repeated hospitalizations predict mortality in the community population with heart failure. American Heart Journal, 154(2), 260–266. https://doi.org/10.1016/j.ahj.2007.01.041.CrossRefPubMed

Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., et al. (2013). Forecasting the impact of heart failure in the United States. Circulation: Heart Failure, 6(3), 606–619. https://doi.org/10.1161/HHF.0b013e318291329a.CrossRef

Ross, J. S., Chen, J., Lin, Z., Bueno, H., Curtis, J. P., Keenan, P. S., …, & Krumholz, H. M. (2010). Recent national trends in readmission rates after heart failure hospitalization. Circulation: Heart Failure, 3(1), 97–103. https://doi.org/10.1161/CIRCHEARTFAILURE.109.885210.

Lewin, J., Ledwidge, M., O’Loughlin, C., McNally, C., & McDonald, K. (2005). Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? European Journal of Heart Failure, 7(6), 953–957. https://doi.org/10.1016/j.ejheart.2005.06.003.CrossRefPubMed

10.

Adamson, P. B. (2009). Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Current Heart Failure Reports, 6(4), 287–292.CrossRefPubMed

11.

Roberts, E., Ludman, A. J., Dworzynski, K., Al-Mohammad, A., Cowie, M. R., McMurray, J. J. V., & Mant, J. (2015). The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ, 350, h910. https://doi.org/10.1136/bmj.h910.CrossRefPubMedPubMedCentral

12.

Davenport, C., Cheng, E. Y. L., Kwok, Y. T. T., Lai, A. H. O., Wakabayashi, T., Hyde, C., & Connock, M. (2006). Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. The British Journal of General Practice, 56(522), 48–56.PubMedPubMedCentral

13.

Chaudhry, S. I., Mattera, J. A., Curtis, J. P., Spertus, J. A., Herrin, J., Lin, Z., …, & Krumholz, H. M. (2010). Telemonitoring in patients with heart failure. New England Journal of Medicine, 363(24), 2301–2309. https://doi.org/10.1056/NEJMoa1010029.

14.

Koehler, F., Winkler, S., Schieber, M., Sechtem, U., Stangl, K., Bohm, M., …, & on behalf of the Telemedical Interventional Monitoring in Heart Failure Investigators. (2011). Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation, 123(17), 1873–1880. https://doi.org/10.1161/CIRCULATIONAHA.111.018473.

15.

Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., et al. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. The Lancet, 377(9766), 658–666. https://doi.org/10.1016/S0140-6736(11)60101-3.CrossRef

16.

Abraham, W. T., & Perl, L. (2017). Implantable hemodynamic monitoring for heart failure patients. Journal of the American College of Cardiology, 70(3), 389–398. https://doi.org/10.1016/j.jacc.2017.05.052.CrossRefPubMed

17.

Yu, C.-M., Wang, L., Chau, E., Chan, R. H.-W., Kong, S.-L., Tang, M.-O., …, & Lau, C.-P. (2005). Intrathoracic impedance monitoring in patients with heart failure. Circulation, 112(6), 841–848. https://doi.org/10.1161/CIRCULATIONAHA.104.492207.

18.

Abraham, W. T., Stevenson, L. W., Bourge, R. C., Lindenfeld, J. A., Bauman, J. G., & Adamson, P. B. (2016). Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. The Lancet, 387(10017), 453–461. https://doi.org/10.1016/S0140-6736(15)00723-0.CrossRef

19.

Desai, A. S., Bhimaraj, A., Bharmi, R., Jermyn, R., Bhatt, K., Shavelle, D., …, & Heywood, J. T. (2017). Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in “real-world” clinical practice. Journal of the American College of Cardiology, 69(19), 2357–2365. https://doi.org/10.1016/j.jacc.2017.03.009.

20.

Sandhu, A. T., Goldhaber-Fiebert, J. D., Owens, D. K., Turakhia, M. P., Kaiser, D. W., & Heidenreich, P. A. (2016). Cost-effectiveness of implantable pulmonary artery pressure monitoring in? Chronic heart failure. JACC: Heart Failure, 4(5), 368–375. https://doi.org/10.1016/j.jchf.2015.12.015.CrossRefPubMed

21.

Ahn, H. C., Delshad, B., & Baranowski, J. (2016). An implantable pressure sensor for long-term wireless monitoring of cardiac function—first study in man. Journal of Cardiovascular Diseases & Diagnosis. https://doi.org/10.4172/2329-9517.1000252.

22.

Troughton, R. W., Ritzema, J., Eigler, N. L., Melton, I. C., Krum, H., Adamson, P. B., …, & Abraham, W. T. (2011). Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance. Journal of Cardiovascular Translational Research, 4(1), 3–13. https://doi.org/10.1007/s12265-010-9229-z.

23.

Regan, H. K., Lynch, J. J., & Regan, C. P. (2009). Long term assessment of blood pressure transducer drift in rhesus monkeys chronically instrumented with telemetry implants. Journal of Pharmacological and Toxicological Methods, 59(1), 35–38. https://doi.org/10.1016/j.vascn.2008.10.002.CrossRefPubMed

24.

Adamson, P. B., Magalski, A., Braunschweig, F., Böhm, M., Reynolds, D., Steinhaus, D., …, & Bennett, T. (2003). Ongoing right ventricular hemodynamics in heart failure. Journal of the American College of Cardiology, 41(4), 565–571. https://doi.org/10.1016/S0735-1097(02)02896-6.

25.

Guazzi, M., & Borlaug, B. A. (2012). Pulmonary hypertension due to left heart disease. Circulation, 126(8), 975–990. https://doi.org/10.1161/CIRCULATIONAHA.111.085761.CrossRefPubMed

26.

Klein, A. L., Stewart, W. J., Bartlett, J., Cohen, G. I., Kahan, F., Pearce, G., …, & Cosgrove, D. M. (1992). Effects of mitral regurgitation on pulmonary venous flow and left atrial pressure: an intraoperative transesophageal echocardiographic study. Journal of the American College of Cardiology, 20(6), 1345–1352. https://doi.org/10.1016/0735-1097(92)90247-K.

27.

Ritzema-Carter, J. L. T., Smyth, D., Troughton, R. W., Crozier, I. G., Melton, I. C., Richards, A. M., …, & Abraham, W. T. (2006). Dynamic myocardial ischemia caused by circumflex artery stenosis detected by a new implantable left atrial pressure monitoring device. Circulation, 113(15), e705–e706. https://doi.org/10.1161/CIRCULATIONAHA.105.572040.

28.

Ritzema, J., Troughton, R., Melton, I., Crozier, I., Doughty, R., Krum, H., …, & Abraham, W. T. (2010). Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation, 121(9), 1086–1095. https://doi.org/10.1161/CIRCULATIONAHA.108.800490.

29.

Maurer, M. S., Adamson, P. B., Costanzo, M. R., Eigler, N., Gilbert, J., Gold, M. R., …, & Abraham, W. T. (2015). Rationale and design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF). Journal of Cardiac Failure, 21(6), 479–488. https://doi.org/10.1016/j.cardfail.2015.04.012.

30.

Abraham, W. T., Adamson, P. B., Costanzo, M. R., Eigler, N., Gold, M., Klapholz, M., …, & Troughton, R. (2016). Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial. Journal of Cardiac Failure, 22(11), 940. https://doi.org/10.1016/j.cardfail.2016.09.012.

31.

Vinayakumar, D., Bijilesh, U., Sajeev, C. G., Rajesh, G. N., Bastion, C., Kadermuneer, P., …, & Krishnan, M. N. (2016). Correlation of pulmonary capillary wedge pressure with left atrial pressure in patients with mitral stenosis undergoing balloon valvotomy. Indian Heart Journal, 68(2), 143–146. https://doi.org/10.1016/j.ihj.2015.07.050.

32.

Nagy, A. I., Venkateshvaran, A., Dash, P. K., Barooah, B., Merkely, B., Winter, R., & Manouras, A. (2014). The pulmonary capillary wedge pressure accurately reflects both normal and elevated left atrial pressure. American Heart Journal, 167(6), 876–883. https://doi.org/10.1016/j.ahj.2014.01.012.CrossRefPubMed

Titel: A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience
verfasst von: Leor Perl
Elina Soifer
Jozef Bartunek
Dedi Erdheim
Friedrich Köhler
William T. Abraham
David Meerkin
Publikationsdatum: 02.01.2019
Verlag: Springer US
Erschienen in: Journal of Cardiovascular Translational Research / Ausgabe 4/2019
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-018-9856-3

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

A Durable Porcine Pericardial Surgical Bioprosthetic Heart Valve: a Proof of Concept

Upregulation of Circulating Cardiomyocyte-Enriched miR-1 and miR-133 Associate with the Risk of Coronary Artery Disease in Type 2 Diabetes Patients and Serve as Potential Biomarkers

MicroRNA-29b-3p Targets SPARC Gene to Protect Cardiocytes against Autophagy and Apoptosis in Hypoxic-Induced H9c2 Cells

A Promising Treatment of Distal Entry Tears Located in Branched Area of Abdominal Aorta With Coil-Stent Tear Occlusion Device: an Animal Experiment